Levels of short-sightedness (myopia) are increasing rapidly in our society.  Globally, about 22% of the world's population are myopic, with rates higher in urban environments and developed societies such as New Zealand.  While low levels of myopia are not concerning from an eye health point of view, high degrees of myopia are associated with increased risk of serious eye disease.  Conditions such as retinal detachment, glaucoma, and myopic maculopathy are all associated with high levels of short-sightedness. 

Myopia tends to develop either in childhood or during the teens, and typically worsens until the patient is 20-something years of age.  Until recently our options for slowing or stopping progressive myopia were limited.  However, today we do have options that are clinically proven to slow myopic progression, and should be considered if a child looks like they are heading towards high levels of myopia.

Our Myopia Control page has detailed information on the available options, including atropine eye drops and specialised contact lenses.  Please review the information on our site, and feel free to email us if you have any questions.